African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5233

Full Length Research Paper

Expression of peptide nanoparticles containing a porcine reproductive and respiratory syndrome (PRRS) virus epitope in plants

Laura Uribe-Campero
  • Laura Uribe-Campero
  • Departamento de Ingenieria Genetica, CINVESTAV-IPN, Km 9.6 Carretera Irapuato-Leon, C.P. 36821 Irapuato, Guanajuato, Mexico
  • Google Scholar
Hector G. Nunez-Palenius
  • Hector G. Nunez-Palenius
  • Division de Ciencias de la Vida. Campus Irapuato-Salamanca. Universidad de Guanajuato, Exhacienda El Copal s/n, A.P. 311, Irapuato, Gto. C.P. 36500., Mexico
  • Google Scholar
Miguel A. Gomez-Lim*
  • Miguel A. Gomez-Lim*
  • Departamento de Ingenieria Genetica, CINVESTAV-IPN, Km 9.6 Carretera Irapuato-Leon, C.P. 36821 Irapuato, Guanajuato, Mexico
  • Google Scholar


  •  Received: 17 April 2015
  •  Accepted: 18 May 2015
  •  Published: 17 June 2015

References

Babapoor S, Neef T, Mittelholzer C, Girshick T, Garmendia A, Shang H, Khan MI, Burkhard P (2011). A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection. Influenza Res. Treat. vol. 2011, Article ID 126794, 12 pages, 2011. doi:10.1155/2011/126794.
Crossref

 

Bachmann MF, Jennings GT (2010). Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10:787-796.
Crossref

 
 

Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM (1993). The influence of antigen organization on B cell responsiveness. Science 262:1448-1451.
Crossref

 
 

Bae K, Choi J, Jang Y, Ahn S, Hur B (2009). Innovative vaccine production technologies: the evolution and value of vaccine production technologies. Arch. Pharm. Res. 32:465-480.
Crossref

 
 

Botner A, Strandbygaard B, Sorensen KJ, Have P, Madsen KG, Madsen ES, Alexandersen S (1997). Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet. Rec. 141:497-499.
Crossref

 
 

Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
Crossref

 
 

Cano JP, Dee SA, Murtaugh MP, Pijoan C (2007). Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate. Vaccine 25:4382-4391.
Crossref

 
 

Chackerian B, Lenz P, Lowy DR, Schiller JT (2002). Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J. Immunol. 169:6120-6126.
Crossref

 
 

Chan HT, Chia MY, Pang VF, Jeng CR, Do YY, Huang PL (2013). Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol. J. 11:315-324.
Crossref

 
 

Chen Q, Lai H (2013). Plant-derived virus-like particles as vaccines. Hum. Vaccine Immunother. 9:26-49.
Crossref

 
 

Chen X, Liu J (2011). Generation and immunogenicity of transgenic potato expressing the GP5 protein of porcine reproductive and respiratory syndrome virus. J. Virol. Methods 173:153-158.
Crossref

 
 

Chia MY, Hsiao SH, Chan HT, Do YY, Huang PL, Chang HW, Tsai YC, Lin CM, Pang VF, Jeng CR (2011). Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs. Vet. Immunol. Immunopathol. 140:215-225.
Crossref

 
 

Coconi-Linares N, Ortega-Davila E, Lopez-Gonzalez M, Garcia-Machorro J, Garcia-Cordero J, Steinman RM, Cedillo-Barron L, Gomez-Lim MA (2013). Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice. Vaccine 31:2366-2371.
Crossref

 
 

Cruz JL, Zuniga S, Becares M, Sola I, Ceriani JE, Juanola S, Plana J, Enjuanes L (2010). Vectored vaccines to protect against PRRSV. Virus Res. 154:150-160.
Crossref

 
 

Diaz I, Darwich L, Pappaterra G, Pujols J, Mateu E (2006). Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology 351:249-259.
Crossref

 
 

Dokland T (2010). The structural biology of PRRSV. Virus Res. 154:86-97.
Crossref

 
 

Fang Y, Treffers EE, Li Y, Tas A, Sun Z, van der Meer Y, de Ru AH, van Veelen PA, Atkins JF, Snijder EJ, Firth AE (2012) Efficient -2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein. Proc. Natl. Acad. Sci. USA 109:E2920-2928.
Crossref

 
 

Han M, Yoo D (2014). Engineering the PRRS virus genome: Updates and perspectives. Vet. Microbiol. 174:279-295.
Crossref7

 
 

Hanada K, Suzuki Y, Nakane T, Hirose O, Gojobori T (2005). The origin and evolution of porcine reproductive and respiratory syndrome viruses. Mol. Biol. Evol. 22:1024-1031.
Crossref

 
 

Holtkamp D, Kliebenstein JB, Neumann EJ, Zimmerman JJ, Rotto HF, Yoder TK, Wang C, Yeske PE, Mowrer CL, Haley CA (2013). Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J. Swine Health Prod. 21:72-84.

 
 

Hu J, Zhang C (2014). Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine. Transbound. Emerg. Dis. 61:109-120.
Crossref

 
 

Hu Y, Zandi R, Anavitarte A, Knobler CM, Gelbart WM (2008). Packaging of a polymer by a viral capsid: the interplay between polymer length and capsid size. Biophys . J. 94(4):1428-1436.
Crossref

 
 

Huang C, Zhang Q, Feng WH (2015) Regulation and evasion of antiviral immune responses by porcine reproductive and respiratory syndrome virus. Virus Res. 202:101-111.
Crossref

 
 

Jegerlehner A, Tissot A, Lechner F, Sebbel P, Erdmann I, Kundig T, Bachi T, Storni T, Jennings G, Pumpens P, Renner WA, Bachmann MF (2002). A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 20:3104-3112.
Crossref

 
 

Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, Chen H (2006). DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 24:2869-2879.
Crossref

 
 

Kaba SA, Brando C, Guo Q, Mittelholzer C, Raman S, Tropel D, Aebi U, Burkhard P, Lanar DE (2009). A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. J. Immunol. 183:7268-7277.
Crossref

 
 

Kappes MA, Faaberg KS (2015) PRRSV structure, replication and recombination: Origin of phenotype and genotype diversity. Virology 479-480:475-486.
Crossref

 
 

Kappes MA, Miller CL, Faaberg KS (2013) Highly divergent strains of porcine reproductive and respiratory syndrome virus incorporate multiple isoforms of nonstructural protein 2 into virions. J. Virol. 87: 13456-13465.
Crossref

 
 

Kappes MA, Miller CL, Faaberg KS (2015) Porcine reproductive and respiratory syndrome virus nonstructural protein 2 (nsp2) topology and selective isoform integration in artificial membranes. Virology 481:51-62.
Crossref

 
 

Kimman TG, Cornelissen LA, Moormann RJ, Rebel JM, Stockhofe-Zurwieden N (2009). Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 27:3704-3718.
Crossref

 
 

Kumar BV, Raja TK, Wani MR, Sheikh SA, Lone MA, Gowher N, Azooz MM, Muhammad Y, Maryam S, Parvaiz A (2013). Transgenic plants as green factories for vaccine production. Afr. J. Biotechnol. 12:6147-6158.

 
 

Li B, Xiao S, Wang Y, Xu S, Jiang Y, Chen H, Fang L (2009a). Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene. Vaccine 27:1957-1963.
Crossref

 
 

Li J, Jiang P, Li Y, Wang X, Cao J, Wang X, Zeshan B (2009b). HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs. Vaccine 27:825-832.
Crossref

 
 

Liu D, Shi L, Han C, Yu J, Li D, Zhang Y (2012). Validation of reference genes for gene expression studies in virus-infected Nicotiana benthamiana using quantitative real-time PCR. PLoS One 7:e46451.
Crossref

 
 

Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
Crossref

 
 

Lunney JK, Benfield DA, Rowland RR (2010). Porcine reproductive and respiratory syndrome virus: an update on an emerging and re-emerging viral disease of swine. Virus Res. 154:1-6.
Crossref

 
 

Mardassi H, Massie B, Dea S (1996). Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 221: 98-112.
Crossref

 
 

Murtaugh MP, Stadejek T, Abrahante JE, Lam TT, Leung FC (2010). The ever-expanding diversity of porcine reproductive and respiratory syndrome virus. Virus Res. 154:18-30.
Crossref

 
 

Nam HM, Chae KS, Song YJ, Lee NH, Lee JB, Park SY, Song CS, Seo KH, Kang SM, Kim MC, Choi IS (2013). Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch. Virol. 158:1275-1285.
Crossref

 
 

Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ (2005). Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 227:385-392.
Crossref

 
 

Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ (2002). Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J. Virol. 76:4241-4250.
Crossref

 
 

Pimentel TA, Yan Z, Jeffers SA, Holmes KV, Hodges RS, Burkhard P (2009). Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine. Chem. Biol. Drug Des. 73:53-61.
Crossref

 
 

Plagemann PG, Rowland RR, Faaberg KS (2002). The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch. Virol. 147:2327-2347.
Crossref

 
 

Qiu HJ, Tian ZJ, Tong GZ, Zhou YJ, Ni JQ, Luo YZ, Cai XH (2005). Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet. Immunol. Immunopathol. 106:309-319.
Crossref

 
 

Raman S, Machaidze G, Lustig A, Aebi U, Burkhard P (2006). Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles. Nanomedicine 2:95-102.
Crossref

 
 

Rao AL, Duggal R, Lahser F, Hall TC (1994). Analysis of RNA replication in plant viruses. In: Methods in Molecular Virology Techniques. Academic Press. 4:216-236.

 
 

Rascón-Castelo E, Burgara-Estrella A, Mateu E, Hernández J (2015). Immunological features of the non-structural proteins of porcine reproductive and respiratory syndrome virus. Viruses 7:873-886.
Crossref

 
 

Rebeaud F, Bachmann M (2012). Virus-Like Particles as Efficient Delivery Platform to Induce a Potent Immune Response. In: Baschieri S (Ed.). Innovation in Vaccinology: From Design, Through to Delivery and Testing. Springer. pp. 87-122.
Crossref

 
 

Rowland RR, Morrison RB (2012). Challenges and opportunities for the control and elimination of porcine reproductive and respiratory syndrome virus. Transbound. Emerg. Dis. 59(1):55-59.
Crossref

 
 

Salguero FJ, Frossard JP, Rebel JM, Stadejek T, Morgan SB, Graham SP, Steinbach F (2015) Host-pathogen interactions during porcine reproductive and respiratory syndrome virus 1 infection of piglets. Virus Res. 202:135-143.
Crossref

 
 

Schmidt GW, Delaney SK (2010). Stable internal reference genes for normalization of real-time RT-PCR in tobacco (Nicotiana tabacum) during development and abiotic stress. Mol. Genet. Genomics 283: 233-241.
Crossref

 
 

Snijder EJ, Kikkert M, Fang Y (2013). Arterivirus molecular biology and pathogenesis. J. Gen. Virol. 94:2141-2163.
Crossref

 
 

Veit M, Matczuk AK, Sinhadri BC, Krause E, Thaa B (2014) Membrane proteins of arterivirus particles: structure, topology, processing and function. Virus Res. 194:16-36.
Crossref

 
 

Vimolmangkang S, Gasic K, Soria-Guerra R, Rosales-Mendoza S, Moreno-Fierros L, Korban SS (2012). Expression of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus in soybean seed yields an immunogenic antigenic protein. Planta 235: 513-522.
Crossref

 
 

Virgen-Ortiz JJ, Ibarra-Junquera V, Escalante-Minakata P, Osuna-Castro JA, Ornelas-Paz J, Mancilla-Margalli NA, Castaneda-Aguilar RL (2013). Improving sodium dodecyl sulfate polyacrylamide gel electrophoresis detection of low-abundance protein samples by rapid freeze centrifugation. Anal Biochem. 443(2):249-251.
Crossref

 
 

Wissink EH, van Wijk HA, Kroese MV, Weiland E, Meulenberg JJ, Rottier PJ, van Rijn PA (2003). The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. J. Gen. Virol. 84:1535-1543.
Crossref

 
 

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012). Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134.
Crossref

 
 

Zhang H, Kono H, Kubota S (2014). An Integrated Epidemiological and Economic Analysis of Vaccination against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (PRRS) in Thua Thien Hue Province, Vietnam. Asian Australas. J. Anim. Sci. 27:1499-1512.
Crossref

 
 

Zheng Q, Chen D, Li P, Bi Z, Cao R, Zhou B, Chen P (2007). Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV). Virus Genes 35:585-595.
Crossref